Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2023-09-14 00:00:00 ET · period of report 2023-09-12 · accession 0001437749-23-025845 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-14 | 2023-09-12+ | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | $0.5198 | +5,100 | 121.8K | +4% | +$2,651 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-12 | P | A | 100 | $0.51 | 116,827 | D | — | — | (F1) Holdings do not include options to purchase 39,584 shares. |
| 2 | Common | Common Stock | 2023-09-13 | P | A | 5,000 | $0.52 | 121,827 | D | — | — | (F1) Holdings do not include options to purchase 39,584 shares. |